Lymphomas and Leukaemias: State of the Art and Evolving Therapies

Not eligible for ESCO credits

06.01.2012 - 08.01.2012

Mumbai, India

CONFERENCE

Individual
registration Third party
registration*

*Third party registration should be used if you are requesting an individual registration for someone who is not you.
Please note that website registration under your name will be needed before registering someone else to this event.

Description

Chairperson:
F. Cavalli, CH - S.H. Advani, IN

Co-Chairperson:
A. Kapadia , IN - P.M. Parikh, IN

Scientific Co-Ordinators:
B.K. Smruti, IN – A. Borges, IN

Pre-Conference workshop
PHATOLOGY OF LYMPHOMAS AND CLINICO-PATHOLOGICAL CORRELATION
5 January 2012

It is our pleasure to invite you to the 2nd European School of Oncology meeting organised in collaboration with International Conference On Malignant Lymphoma,
Mumbai Oncology Association, Indian Society Of Medical & Pediatrics Oncology, Indian Co-Operative Oncology Network, to be held in Mumbai, 6-8 January 2012. This provides a unique opportunity to interact with a distinguished international and national faculty who will review the state of art treatment and give a glimpse of the next generation of therapies in the management of lymphomas and leukemias. The meeting would utilize a variety of formats including didactic lectures, “My Approach”, talks, panel discussions, meet the experts sessions with case presentations. The meeting would provide a platform for poster and oral presentations. A prelude would be a workshop on pathology of lymphomas and clinico pathological correlation.

LEARNING OBJECTIVES
• Overview of classification and functional imaging in lymphomas
• Discuss recent advances in treatment of lymphomas & leukemias
• Insight into novel therapies and their integration into treatment strategies
• State of the art treatment paradigms of Lymphomas & Leukemias

MAIN TOPICS

Lymphomas:

- Classification
- Imaging
- Diffuse large B Cell Lymphomas
- Mantle Cell Lymphomas
- Follicular Lymphomas
- T-Cell Lymphomas
- Lymphomas in immunocompromised
- Extranodal Lymphomas
- Novel Targets & Agents
- Hodgkin’s Disease

Leukemia:

- CLL & CML Acute Leukemia
- Hairy Cell Leukemia
- Waldenstrom’s Macroglobulinemia
- MDS
- MPD

In collaboration with

INTERNATIONAL CONFERENCE ON MALIGNAT LYMPHOMA LUGANO						MUMBAI ONCOLOGY ASSOCIATION



INDIAN SOCIETY OF MEDICAL & PAEDIATRIC ONCOLOGY						INDIAN CO-OPERATIVE ONCOLOGY NETWORK

General information

ORGANISING SECRETARIAT
(programme, registration, invitation letters,
abstract submission)
Roberta Ventura
European School of Oncology
Via del Bollo, 4
20123 Milan, Italy
Tel: +39 0285464532 - Fax: +39 0285464545
Email: rventura@eso.net

LOCAL ORGANISER
(Registration, Invitation letters, Abstract submission)
Nimesh Bafna
Green Room Media and event Management Services Private Limited
8/2 Krishna bldg, Gokhale Society Lane, Parel
400012 Mumbai
Tel: +91 22 24146482/83
Email: lymphomaandleukaemia2012@gmail.com

CONFERENCE VENUE
ITC Hotel - The Grand Central
Dr. Babasaheb Ambedkar Road, Parel, Mumbai

WORKSHOP VENUE
R.D. Choksi Auditorium
Tata Memorial Hospital
Dr E. Borges Road
Parel, Mumbai

LETTER OF INVITATION
If you require an official letter of invitation in order to attend the conference, please write to the organising secretariat at rventura@eso.net
The letter will assist delegates who need to obtain their governments or departments permission to attend the conference or obtain required visa from Indian-Mission abroad.
The letter of invitation will be released to fully registered participants and does not entitle registrant from exemption in fee.

CERTIFICATE OF ATTENDANCE
All participants will be issued with a certificate of attendance at the close of the conference.

CME ACCREDITATION
CME accreditation is under process and number of points will be declared as soon as we get Maharashtra Medical Council approval.

OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.

INSURANCE
The organizers bear no responsibility for untoward events in relation to the participation in the Conference Participants are advised to take out their own personal and travel insurance coverage.

BADGE
The badge is the only official evidence of registration and should be worn at all times during the course. Loss of badge means loss of registration.

MEDICAL QUIZ
Students can also register to participate in medical quiz which will be based on the learning of the
conference. The final rounds will be conducted on Day 3, Jan 8 2012. There are attractive prizes for the winners of the quiz. The students have to register for the quiz as well. Registration for the Quiz is free.

DEADLINES
Abstracts:
25 December 2011
Early registration:
by 25 December 2011
Late registration:
from 26 December 2011
Hotel accommodation:
by 25 December 2011

Faculty list

INTERNATIONAL FACULTY
S. Branford, University of Adelaide, AU
F. Cavalli, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
R.E. Clark, University of Liverpool, UK
D. Hoelzer, University of Frankfurt, DE
P. Johnson, University of Southampton, UK
T.A. Lister, St. Bartholomew's Hospital, London, UK
M.T. Moonim, Guy’s and St. Thomas’ Hospitals NHS Foundation Trust, London, UK
K. Naresh, Imperial College, London, UK
M. Pfreundschuh, Saarland University, Homburg, DE
A.D. Zelenetz, Memorial Sloan-Kettering Cancer Center, New York, US
P.L. Zinzani, University of Bologna, IT
E. Zucca, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH

NATIONAL FACULTY

Dr. A.A. Ranade, Pune Dr. (Brig) Ajay Sharma, Delhi Dr. Ajay Bapna, Jaipur Dr. Abhay Bhave, Mumbai Dr. Anand Pathak, Nagpur Dr. Anil Singhvi, Indore Dr. Anupama Hooda, Delhi Dr. Asha Kapadia, Mumbai Dr. Ashish Bakshi, Mumbai Dr. Ashish Dixit, Bangalore Dr. Ashish Mukherjee, Kolkatta Dr. Ashok Kumar Vaid, Delhi Dr. Atul Sharma, Delhi Dr. B.A. Krishna, Mumbai Dr. B.K. Smurti, Mumbai Dr. Bhavin Shah, Ahmedabad Dr. Bhawna Sirohi, Delhi Dr. Biju George, Vellore Dr. Boman Dhabhar, Mumbai Dr. (Col). Deepak K. Mishra, Delhi Dr. Dinesh. C. Doval, Delhi Dr. Dinesh Bhurani, Delhi Dr. Dinesh Pendharkar, Mumbai Dr. G.S. Bhattacharya, Kolkatta Dr. Ganapati Ramanan, Chennai Dr. Govind Babu, Bangalore Dr. Hari Menon, Mumbai Dr. Hemant Malhotra, Jaipur Dr. Jay Mehta, Mumbai Dr. Jose M. Easow, Chennai Dr. K.C. Lakshmiah, Bangalore Dr. Krishna Prasad, Mangalore Dr. M Joseph John, Ludhiana Dr. M.B. Agarwal, Mumbai Dr. Maddali Srinivas, Hyderabad Dr. Maheboob Basade, Mumbai Dr. Malay Ghosh, Kolkatta Dr. Mitu Shrikhande, Delhi Dr. Mukesh Desai, Mumbai Dr. Nalini Kilara, Bangalore Dr. Naresh Somani, Jaipur Dr. Naryanan Prasad, Bangalore			Dr. Neelam Varma, Delhi Dr. P.K. Gogoi, Guwahati Dr. Pankaj Malhotra, Chandigarh Dr. Pankaj Shah, Ahmedabad Dr. Prantar Chakrabarti, Kolkatta Dr. Prashanth Ganesan, Chennai Dr. Pratibha S. Amare, Mumbai Dr. Purvish M. Pairkh, Mumbai Dr. R Gopal, Mumbai Dr. Rahul Bhargava, Delhi Dr. Rajeev Rajendranath, Chennai Dr. Rajesh Kashyap, Lucknow Dr. Rakesh Chopra, Delhi Dr. Ramesh Nimaggadda, Chennai Dr. (Col). R Ranga Rao, Delhi Dr. Ravi Shankar, Vizag Dr. Reena Nair, Mumbai Dr. Renu Saxena, Delhi Dr. S.D. Banavali, Mumbai Dr. Satya Dattatreya, Hyderabad Dr. Sameer Melinkeri, Pune Dr. Sandeep Goyle, Mumbai Dr. Seema Bhatwadekar, Baroda Dr. Senthil Rajappa, Hyderabad Dr. Sharat Damodar, Bangalore Dr. Shashikant Apte, Pune Dr. Shekar Patil, Bangalore Dr. Shilin Shukla, Ahmedabad Dr. Shyam Aggarwal, Delhi Dr. Siddhartha Laskar, Mumbai Dr. Sunil Parikh, Mumbai Dr. T.G. Sagar, Chennai Dr. T.P. Sahoo, Bhopal Dr. T. Raja, Chennai Dr. Tanuja Shet, Mumbai Dr. Tapan Saikia, Mumbai Dr. Tulika Seth, Delhi Dr. Uday Deotare, Ahmedabad Dr. Vijay Ramanan, Pune Dr. Vinod Raina, Delhi Dr. (Col) Velu Nair, Pune Dr. V.P. Antia, Mumbai

Programme

5 January - Pre-Conference Workshop


*Pathology of lymphomas and clinico-pathological correlation*

8:30	WHO 2008: Its relevance in low resource settings
9:00	New concepts in Hodgkin Lymphoma
9:30	Diffuse large B cell Lymphoma: the clinical relevance of heterogeneity
10:00	Understanding T cells and their neoplastic counterparts • T cell subsets and their functions in the immune response NIH • T cell lymphomas - An overview • AILD
11:00	*Tea break*
11:30	Approaches to grey zones in lymphoma diagnosis • DLBL vs Burkitt lymphoma • DLBL vs Ccassical Hodgkin lymphoma • NLPHL vs NHL of T cell rich B cell type • A clinical perspective
13:00	Lunch break
14:00	Nodal marginal zone lymphoma: A diagnosis by exclusion?
14:30	In-situ lymphomas and other indolent clonal proliferations
15:00	HIV related lymph node disease
15:30	The emerging role of the microenvironment in lymphoma
16:00	Tea break
16:30	Practical issues • Flow cytometry in lymph node diagnosis • CD30 and CD15 in lymph node diagnosis • Detecting EBV in lymphoid tissues: when, why and how • Molecular biology in routine lymph node diagnosis
17:30	Slide discussions - 6 cases: TMH, Raheja, Piramal

6 January - Conference


Scientific programme

7:30	*Registration*
9:00	*Poster Display (Until 17:00)*
8:00	*Clinico - Pathological correlation and oral presentations (until 10:00)*
8:00	*Clinico - Pathological correlation*
9:00	Oral presentations
Session 1: PLENARY LECTURES Chairpersons: T. Sagar, IN - P. Shah, IN
10:00	BEYOND 2008 WHO CLASSIFICATION “Practical application for clinicians” A.D. Zelenetz, US
10:20	TAILORING THERAPY IN LYMPHOMAS “Are we there ?” P. Johnson, UK Chairpersons: B.A. Krishna, IN - A. Kapadia, IN
10:40	"CURRENT STATUS OF FUNCTIONAL IMAGING IN LYMPHOMAS “Staging to adaptive therapy" T.A. Lister, UK
11:00	Tea break
Session 2: DIFFUSE LARGE B-CELL LYMPHOMAS (DLBCL) Chairpersons: S.D. Banavali, IN - A. Borges, IN
11:15	Molecular subtypes of DLBCL “Any implications for treatment ?” K. Naresh, UK
11:40	New challenges in advanced DLBCL (including GREY ZONE) M. Pfreundschuh, DE
12:00	Novel targets and therapies for DLBCL P. Johnson, UK
12:20	DLBCL: my approach to treatment F. Cavalli, CH
12:40	Clinical dilemmas: case discussion Moderator: H. Malhotra, IN Panelists: G. Ramanan, IN - R. Nimmagadda, IN - J.Mehta, IN P. Johnson, UK - F. Cavalli, CH - S. Laskar, IN
13:00	*Lunch break*
Session 3: MANTLE CELL LYMPHOMAS (MCL) Chairpersons: S. Shukla, IN - T. Saikia, IN
13:30	MCL: Biology and subgroups Speaker to be confirmed
13:50	Treatment challenges in MCL, including maintenance P.L. Zinzani, IT
14:20	Novel agents in MCL P. Johnson, UK
14:35	Treatment of MCL: My approach A.D. Zelenetz, US
14:50	Clinical dilemmas: case discussion Moderator: B.K. Smruti, IN Panelists: R. Chopra, IN - H. Menon, IN - D.C. Doval, IN - T. Seth, IN - P.L. Zinzani, IT - P. Johnson, UK
Session 4: FOLLICULAR LYMPHOMAS (FL) Chairpersons: S.H. Advani, IN - D. Pendharkar, IN
15:15	FL: Treatment including first line/maintenance F. Cavalli, CH
15:45	FL: Transformation, biology and treatment E. Zucca, CH
16:00	FL: my approach to treatment T.A. Lister, UK
16:15	Clinical dilemmas: case discussion Moderator: S. Rajappa, IN Panelists: A.K. Vaid, IN - A. Bakshi, IN - A. Pathak, IN - F. Cavalli, CH - E. Zucca, CH
16:45	*Tea break*
Session 5: LYMPHOMAS IN THE IMMUNOCOMPROMISED Chairpersons: M. Srinivas, IN - K.C. Lakshmaiah, IN
17:00	Post transplant Lymphoproliferative disorders: diagnosis and treatment P.L. Zinzani, IT
17:20	Chemoimmunotherapy in Burkitt lymphoma D. Hoelzer, DE
17:40	Clinical dilemmas : case discussion Moderator: R.R. Rao, IN Panelists: K. Prasad, IN - A. Sharma, IN - M. Sengar, IN - D. Hoelzer, DE - P.L. Zinzani, IT

19:00	INAUGURATION OF THE CONFERENCE

19:30	SATELLITE SYMPOSIUM (SALVAGING RELAPSED LYMPHOMAS: CURRENT STRATEGIES TO NOVEL TERAPEUTICS) Chairpersons: S.H. Advani, IN - F. Jijina, IN
19:30	New mechanistic insights into antibody therapy P. Johnson, UK
19:45	Monoclonal antibodies beyond CD20; the next generation P.L. Zinzani, IT
20:00	New drug combinations in NHL E. Zucca, CH
20:15	Salvaging Relapsed/Refractory follicular lymphomas post rituximab T.A. Lister, UK
20:30	Relapsed DLBCL and MCL: Challenging issues F. Cavalli, CH
20:45	Emerging strategies in CD30 expressing NHL A.D. Zelenetz, US
21:00	Clinical dilemmas: case discussion Moderator: T. Raja, IN Panelists: V. Ramanan, IN - M.M. Basade, IN - T. Saikia, IN - T.P. Sahoo, IN - B. Dhabhar, IN - N. Khattry, IN

7 January

7:00	*Meet the Expert*
8:00	*Oral Presentation*
9:00	*Poster Display (Until 17:00)*
Session 6: T-CELL LYMPHOMAS Chairpersons: R. Shankar, IN - R. Gopal, IN
9:00	Optimizing current strategies in the different subtypes of T-Cell lymphomas P. Johnson, UK
9:20	Novel therapies for T-Cell lymphomas P.L. Zinzani, IT
9:40	Clinical dilemmas: case discussion Moderator: G. Babu, IN Panelists: P.S. Dattatreya, IN - S. Patil, IN - P. Chakrabarti, IN - P. Ganesan, IN - P. Johnson, UK - P.L. Zinzani, IT
Session 7: EXTRANODAL LYMPHOMAS Chairpersons: R. Nimmagadda, IN - N. Somani, IN
10:00	Aggressive Extranodal lymphomas M. Pfreundschuh, DE
10:20	Cutaneous lymphomas P.L. Zinazani, IT
10:40	Marginal zone lymphomas E. Zucca, CH
11:00	Clinical Dilemmas: case discussion Moderator: G.S. Bhattacharya, IN Panelists: E. Zucca, CH - P.L. Zinzani, IT - A. Bapna, IN - R. Rajendranath, IN - A. Singhvi, IN
11:20	*Tea break*
Session 8: HODGKIN’S LYMPHOMA AND ELDERLY PATIENTS Chairpersons: T.G. Sagar, IN - A.A. Ranade, IN
11:30	Treatment of Hodgkin’s lymphoma, including NLPHL T.A. Lister, UK
11:50	Salvaging relapsed/refractory Hodgkin's lymphoma A.D. Zelenetz, US
12:10	Treatment of all lymphomas in the elderly F. Cavalli, CH
12:30	Clinical dilemmas: case discussion Moderator: B. Sirohi, IN Panelists: S. Goyle, IN - A. Hooda, IN - A. Mukherjee, IN - A.D. Zelenetz, US - S. Bhatwadekar, IN
13:00	*Lunch symposium*
Session 9: MY APPROACH TO HAEMATOLOGICAL MALIGNANCIES 2012 Chairpersons: M. Ghosh, IN - S. Verma, IN
13:45	Waldenström’s Macroglobulinemia E. Zucca, CH
14:05	Lymphoblastic lymphomas D. Hoelzer, DE
14:25	Hairy cell leukemia M. Pfreundschuh, DE
14:45	High risk CLL F. Cavalli, CH
15:05	Adult ALL D. Hoelzer, DE
15:25	Clinical dilemmas: case discussion Moderator: A. Sharma, IN Panelists: M. Joseph John, IN - A. Bhave, IN - T. Seth, IN - S. Melinkeri, IN - R. Kashyapin, IN
15:55	*Tea break*
Session 10: INDIAN DATA: LYMPHOMAS Chairpersons: P.M. Parikh, IN - F. Cavalli, CH
16:10	DLBCL and indolent lymphomas V. Raina, IN
16:30	T-Cell lymphoma R. Nair, IN
16:50	Mantle cell lymphoma K.C. Lakshmaiah, IN
17:10	Hodgkin’s lymphoma P. Ganesan, IN
18:30	SYMPOSIUM on take home messages from the year 2011 Details to be finalised

8 January

7:30	*Meet the experts*
8:30	Oral Presentation
9:00	*Poster Display* *(Until 17:00)*
Session 11: AML AND MDS Chairpersons: M. Desai, IN - D. Bhurani, IN
9:30	AML - Molecular signatures and optimizing therapy R.E. Clark , UK
9:50	Elderly AML any progress S. Damodar , IN
10:10	MDS-Prognostic classification and risk assessment D.K. Mishra, IN
10:30	MDS-Recent therapeutic advances and future options: “To trick or to treat” P. Malhotra, IN
10:50	Clinical dilemmas: case discussion Moderator: P. Malhotra, IN Panelists: R. Bhargava, IN - J. Easow, IN - S.D. Banavali, IN - B. Shah, IN - P. Amore, IN - M. Shrikhande, IN
11:15	*Tea break*
Session 12: SYMPOSIUM: CHRONIC MYELOID LEUKEMIA Invited International Speaker: S. Branford, AU
13:00	Lunch break
Session 13: MYELOPROLIFERATIVE NEOPLASMS Chairpersons: S. Parikh, IN - N. Verma, IN
13:30	Point of care diagnostic algorithm and prognostic scoring system B. George, IN
13:50	Molecular pathophysiology and clinical understanding T. Saikia, IN
14:10	Therapeutic approach: Critical concepts and management recommendations S. Apte, IN
14:30	Clinical dilemmas: case discussion Moderator: A. Dixit, IN Panelists: R. Saxena, IN - U. Deotre, IN - P. Gogoi, IN - T. Saikia, IN - P. Mishra, IN
14:50	QUIZ COMPETITION
15:50	PRESENTATION OF AWARDS Oral presentation Quiz competition Judges: P.M. Parikh, IN - R. Saxena, IN - P. Malhotra, IN

Abstract

ABSTRACT SUBMISSION
Participants with new data relevant to the subject of the conference are encouraged to submit one abstract to be considered for poster presentation and inclusion in the conference book. Only abstracts that have been reviewed and accepted by the Conference Committee will be presented.

The five best abstracts will be accepted for oral presentation and the Best Poster Award.

Deadline for submission: 25 December 2011

Instructions for abstract submission

Abstracts should be submitted online here below (or sent to abstract.esoll2012@gmail.com)
• Abstracts must be written in English and the text should not exceed 2000 characters (including title)
• The title should appear in capital letters
• For each author, type surname followed by given name and initials (presenting author in capital letters)
• List affiliations after the author’s list
• The full address with telephone, fax numbers, and e-mail address of the corresponding author must be provided. The corresponding author will receive all the subsequent communication concerning the submitted abstract, preferably by e-mail
• For abstracts accepted for poster presentation, the corresponding author will be the presenting author
• It is the responsibility of the corresponding author to ascertain whether all authors are aware of the content of the abstract before submission

The submission outcome will be notified after the deadline and the corresponding/presenting author will be required to register to the conference (pre-registration deadline: 19 December).

« Back to "2012"